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CORRECTION
Correction: Correction: A Novel Rhabdovirus
Associated with Acute Hemorrhagic Fever in
Central Africa
Gilda Grard, Joseph N. Fair, Deanna Lee, Elizabeth Slikas, Imke Steffen, Jean-
Jacques Muyembe, Taylor Sittler, Narayanan Veeraraghavan, J. Graham Ruby,
Chunlin Wang, Maria Makuwa, Prime Mulembakani, Robert B. Tesh, Jonna Mazet, Anne
W. Rimoin, Travis Taylor, Bradley S. Schneider, Graham Simmons, Eric Delwart, Nathan
D. Wolfe, Charles Y. Chiu, Eric M. Leroy
In the correction published on March 18, 2016 there were errors present in Fig 1.
In the Fig 1 presented in the March 18, 2016 correction, labels were misnamed and the
shading was incorrect. “Bas-Congo hemorrhagic fever” has been changed to “Mangala hemor-
rhagic fever” and “Lujo hemorrhagic fever” was missing from the key and the map. The loca-
tion of Mangala and Boma were switched. In addition, some shading on the map was
incorrect. Guinea was incorrectly labeled as being affected by Crimean-Congo hemorrhagic
fever instead of Lassa hemorrhagic fever. Ivory Coast was incorrectly labeled as being affected
by Lassa hemorrhagic fever instead of Ebola hemorrhagic fever. Ghana was mislabeled as hav-
ing been affected by Ebola. North Sudan was also mislabeled as having been affected by Ebola.
Two areas were missing labels indicating the presence of Lujo hemorrhagic fever. The authors
have now corrected these errors and have provided a new corrected Fig 1. The corrected figure
does not take into account changes in the epidemiology of the hemorrhagic fever viruses (e.g.
the 2013 West African Ebola virus epidemic) since the time the study was published.
In addition, questions have been raised regarding the availability of additional data relevant
to diagnoses of patients in Table 1. The authors indicated that no additional data relating to
the field samples tested at International Centre for Medical Research at Franceville (CIRMF)
are available. All relevant data was already present in the paper and Table 1, as originally
published.
Further, there have been requests to verify the blot used to correct Supporting Information
S2 Fig. The authors have now supplied complete annotations for the blot in order to confirm
the proper labeling of the lanes. The raw, uncropped blot with all lanes annotated is available
as Supporting Information S1 File. The editors are satisfied that the materials provided answer
any outstanding questions about the blot.
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Supporting information
S1 File. PDF. Lane 1: empty lane. Lane 2: rotavirus RNA (positive control). Lane 3: rotavirus
next-generation sequencing (NGS) library (positive control). Lane 4: methicillin-resistant
Staphylococcus aureus NGS library; made during period of rotavirus contamination and posi-
tive for rotavirus by NGS. Lane 5: amplified complementary DNA (cDNA) from the BASV-
positive serum sample. Lane 6: DNA ladder. Lane 7: reverse-transcribed cDNA from the
BASV-positive serum sample. Lane 8: methicillin-resistant Staphylococcus aureus NGS library;
made after period of rotavirus contamination and negative for rotavirus by NGS. Lane 9:
extracted RNA from the BASV-positive serum sample. Lane 10: water (negative control).
(PDF)
Fig 1. Map of Africa showing countries that are affected by viral hemorrhagic fever (VHF) outbreaks. Ebola VHF is pictured in orange,
Marburg VHF in green, Crimean-Congo HF in violet, Lujo VHF in pink, and Lassa VHF in blue. Yellow fever and dengue VHF, which exhibit a wide
geographic distribution throughout Sub-Saharan Africa, are not shown. Mangala village, located in the Bas-Congo province in DRC, is
represented by a red star.
https://doi.org/10.1371/journal.ppat.1006583.g001
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